Skip to main content

Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management.

Publication ,  Journal Article
Bair, CA; Cate, J; Chu, A; Kuller, JA; Dotters-Katz, SK
Published in: Obstet Gynecol Surv
November 2024

IMPORTANCE: Fetal macrosomia (FM) is common in clinical practice and carries increased risk of adverse maternal and neonatal health outcomes. Maternal diabetes mellitus (DM) is a well-known cause of macrosomia with significant research and guidelines focusing on macrosomia in this population. Less is known about causes, prevention, and clinical management for suspected FM in individuals without diabetes. OBJECTIVE: The objective of this review is to describe the risk factors associated with nondiabetic FM, review risks associated with macrosomia in pregnancy, and potential treatment considerations for this condition. EVIDENCE ACQUISITION: Original research articles, review articles, and guidelines on macrosomia were reviewed. RESULTS: Risk factors for macrosomia in patients without DM include previous delivery of an infant with macrosomia, excessive pregnancy weight gain, and obesity. Maternal complications of FM include higher rates of cesarean delivery, postpartum hemorrhage, and vaginal laceration. Fetal complications include shoulder dystocia, decreased Apgar scores, and increased risk of childhood obesity. Exercise during pregnancy has been shown to reduce the risk of FM. Induction of labor prior to 39 weeks is not recommended in the setting of suspected macrosomia as there is a lack of adequate evidence to support that this decreases adverse neonatal or maternal outcomes. In addition, elective cesarean delivery for suspected macrosomia is not recommended to be considered unless estimated fetal weight is greater than 5000 g in the absence of DM. CONCLUSIONS AND RELEVANCE: Delivery of an infant with macrosomia in patients without DM has increased maternal and fetal risks. Predicting infants who will meet criteria for macrosomia is challenging. More research is needed to identify ways to accurately estimate fetal weight, interventions to prevent macrosomia, and additional ways to mitigate risk in patients without DM who have suspected FM.

Duke Scholars

Published In

Obstet Gynecol Surv

DOI

EISSN

1533-9866

Publication Date

November 2024

Volume

79

Issue

11

Start / End Page

653 / 664

Location

United States

Related Subject Headings

  • Risk Factors
  • Pregnancy Outcome
  • Pregnancy Complications
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Obesity
  • Infant, Newborn
  • Humans
  • Fetal Macrosomia
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bair, C. A., Cate, J., Chu, A., Kuller, J. A., & Dotters-Katz, S. K. (2024). Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management. Obstet Gynecol Surv, 79(11), 653–664. https://doi.org/10.1097/OGX.0000000000001326
Bair, Courtney A., Jennifer Cate, Allison Chu, Jeffrey A. Kuller, and Sarah K. Dotters-Katz. “Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management.Obstet Gynecol Surv 79, no. 11 (November 2024): 653–64. https://doi.org/10.1097/OGX.0000000000001326.
Bair CA, Cate J, Chu A, Kuller JA, Dotters-Katz SK. Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management. Obstet Gynecol Surv. 2024 Nov;79(11):653–64.
Bair, Courtney A., et al. “Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management.Obstet Gynecol Surv, vol. 79, no. 11, Nov. 2024, pp. 653–64. Pubmed, doi:10.1097/OGX.0000000000001326.
Bair CA, Cate J, Chu A, Kuller JA, Dotters-Katz SK. Nondiabetic Fetal Macrosomia: Causes, Outcomes, and Clinical Management. Obstet Gynecol Surv. 2024 Nov;79(11):653–664.

Published In

Obstet Gynecol Surv

DOI

EISSN

1533-9866

Publication Date

November 2024

Volume

79

Issue

11

Start / End Page

653 / 664

Location

United States

Related Subject Headings

  • Risk Factors
  • Pregnancy Outcome
  • Pregnancy Complications
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Obesity
  • Infant, Newborn
  • Humans
  • Fetal Macrosomia
  • Female